Source: RgStudio / Getty A new weight loss medication called retatrutide is drawing attention, though it hasn’t yet been approved by the FDA. Early studies show promising results, with the potential to help people lose a significant amount of weight. Developed by Eli Lilly, retatrutide is a triple-hormone receptor agonist, meaning it targets three key hormones involved in regulating hunger and metabolism: GIP (gastric inhibitory peptide), GLP-1 …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.